<DOC>
	<DOCNO>NCT01834690</DOCNO>
	<brief_summary>Conventionally , outcome liver transplantation usually report term graft patient survival , medical surgical complication , lack health-related quality life ( HRQOL ) might associate immunosuppression complication ( e.g. , diabetes , hypertension , dyslipidemia , obesity , metabolic syndrome , cardiovascular disease , renal dysfunction , osteoporosis , de novo malignancy ) , disease recurrence , rejection transplantation .</brief_summary>
	<brief_title>Uses Immunosuppression Therapy Patients With Liver Transplantation</brief_title>
	<detailed_description>Specific aim propose achieve study : 1 . To compare graft patient survival rate , incidence treatment-related adverse effect different pattern immunosuppression combination among patient receive post-liver transplant care Kaohsiung Chang Gung Memorial Hospital ( KCGMH ) , Taiwan . 2 . To quantify long-term health impact immunosuppressive regimen quality-adjusted life expectancy ( QALE ) , loss-of-QALE relate immunosuppression therapy , type transplantation .</detailed_description>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Aim 1 : age liver transplantation least 20 year Aim 2 : age liver transplantation least 20 year decease patient obtain inform consent age &lt; 20 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Liver transplantation/epidemiology</keyword>
	<keyword>Liver transplantation/pharmacology</keyword>
	<keyword>Health status/drug effect</keyword>
	<keyword>Agents , immunosuppressive agent</keyword>
</DOC>